Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
CD8-mediated inflammatory central nervous system disorders.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients.
Oral BG-12 in multiple sclerosis.
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Pages
« first
‹ previous
…
231
232
233
234
235
236
237
238
239
…
next ›
last »